Bayer Inc. et al. v. Cobalt Pharmaceuticals Co., 2016 FC 1013

This document cites

• Eli Lilly Canada Inc. v. Mylan Pharmaceuticals ULC et al., (2015) 474 F.T.R. 256 (FC)
• Amgen Canada Inc. et al. v. Apotex Inc. et al., 2015 FC 1261
• Sanofi-Synthelabo Canada Inc. et al. v. Apotex Inc. et al., (2008) 381 N.R. 125 (SCC)
• AstraZeneca Canada Inc. et al. v. Mylan Pharmaceuticals ULC et al., (2012) 432 N.R. 292 (FCA)
• Wenzel Downhole Tools Ltd. et al. v. National-Oilwell Canada Ltd. et al., (2012) 443 N.R. 173 (FCA)



See all quotations

• Allergan Inc. et al. v. Canada (Minister of Health) et al., (2012) 440 N.R. 269 (FCA)
• Pfizer Canada Inc. et al. v. Novopharm Ltd. et al., (2012) 436 N.R. 299 (SCC)
• Shire Canada Inc. v. Apotex Inc. et al., 2016 FC 382
• Uponor AB v. Heatlink Group Inc. et al., 2016 FC 320
• Bayer Inc. et al. v. Cobalt Pharmaceuticals Co. et al., (2015) 474 N.R. 311 (FCA)
• Eli Lilly Canada Inc. v. Novopharm Ltd. et al., 2007 FCA 359
• Blank v. Canada (Minister of Justice), (2009) 373 F.T.R. 1 (FC)
• AstraZeneca Canada Inc. et al. v. Apotex Inc. et al., (2015) 474 N.R. 296 (FCA)
• Apotex Inc. et al. v. Wellcome Foundation Ltd., (2009) 354 F.T.R. 164 (FC)
• Whirlpool Corp. et al. v. Camco Inc. et al., (2000) 263 N.R. 88 (SCC)
• AstraZeneca Canada Inc. et al. v. Apotex Inc. et al., (2014) 457 F.T.R. 227 (FC)
• Merck & Co. et al. v. Apotex Inc. et al., (2010) 381 F.T.R. 162 (FC)
• Free World Trust v. Électro Santé Inc. et al., (2000) 263 N.R. 150 (SCC)
• Weatherford Canada Ltd. et al. v. Corlac Inc. et al., (2011) 422 N.R. 49 (FCA)
• Apotex Inc. v. Sanofi-Aventis, (2013) 447 N.R. 313 (FCA)
• Eli Lilly & Co. et al. v. Novopharm Ltd. et al., (1998) 227 N.R. 201 (SCC)
• Pfizer Canada Inc. et al. v. Canada (Minister of Health) et al., (2005) 285 F.T.R. 1 (FC)
• Monsanto Canada Inc. et al. v. Schmeiser et al., (2004) 320 N.R. 201 (SCC)
• Morin v. Can., (2005) 332 N.R. 109 (FCA)
• GlaxoSmithKline Inc. et al. v. Pharmascience Inc. et al., (2011) 385 F.T.R. 157 (FC)
• Baker Petrolite Corp. et al. v. Canwell Enviro-Industries Ltd. et al., (2002) 288 N.R. 201 (FCA)
• Eli Lilly Canada Inc. v. Apotex Inc. et al., 2015 FC 875
• Bayer Inc. et al. v. Cobalt Pharmaceuticals Co. et al., (2013) 441 F.T.R. 72 (FC)
• Pfizer Canada Inc. et al. v. Apotex Inc. et al., (2014) 465 N.R. 306 (FCA)
• International Corona Resources Ltd. v. LAC Minerals Ltd., (1989) 101 N.R. 239 (SCC)
• Eli Lilly & Co. et al. v. Apotex Inc., (2009) 351 F.T.R. 1 (FC)
• Eli Lilly Canada Inc. v. Mylan Pharmaceuticals ULC et al., 2015 FCA 286
• Wenzel Downhole Tools Ltd. et al. v. National-Oilwell Canada Ltd. et al., (2011) 401 F.T.R. 74 (FC)
• AstraZeneca Canada Inc. et al. v. Mylan Pharmaceuticals ULC et al., 2011 FC 1023
• Bayer Inc. et al. v. Apotex Inc. et al., (2014) 454 F.T.R. 48 (FC)